Asthma Trial, Recruiting (NCT06278662)

Asthma Trial, Recruiting NCT06278662 Sponsor: Mattienne van der Kamp Condition: Asthma

Printed from Voxsanity (voxsanity.com.au) — NCT06278662 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Asthma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child is between 4 and 18 years old
The child is currently a patient in the children's department at Medisch Spectrum Twente hospital
The child has been diagnosed with asthma by a children's doctor, based on typical symptoms such as wheezing (especially at night), shortness of breath, or coughing that is triggered by things like exercise, allergies, infections, or weather changes
The child may also have a family history of allergies or asthma as part of their diagnosis
The child has breathing test results that show limited airflow, confirmed by at least one of the following: an abnormal lung function ratio, a significant improvement in breathing after using a reliever inhaler, a significant drop in lung function during an exercise test, or notable changes in lung function across different test appointments (confirm with trial site)

Who may not be able to join:

The child and/or their parent(s) do not have a sufficient understanding of the Dutch language to understand and answer questions in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31 53 487 23 10

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06278662

Sponsor: Mattienne van der Kamp

Phase: Not Applicable

Status: Recruiting

Condition: Asthma

Trial contact: +31 53 487 23 10

More information: https://clinicaltrials.gov/study/NCT06278662

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child is between 4 and 18 years old
The child is currently a patient in the children's department at Medisch Spectrum Twente hospital
The child has been diagnosed with asthma by a children's doctor, based on typical symptoms such as wheezing (especially at night), shortness of breath, or coughing that is triggered by things like exercise, allergies, infections, or weather changes
The child may also have a family history of allergies or asthma as part of their diagnosis
The child has breathing test results that show limited airflow, confirmed by at least one of the following: an abnormal lung function ratio, a significant improvement in breathing after using a reliever inhaler, a significant drop in lung function during an exercise test, or notable changes in lung function across different test appointments (confirm with trial site)

Who may not be able to join:

The child and/or their parent(s) do not have a sufficient understanding of the Dutch language to understand and answer questions in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mattienne van der Kamp

Registry

ClinicalTrials.gov

Start date

1 April 2024

Est. completion

1 April 2034

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Asthma control; Pediatric Asthma Quality of Life; Quality of care; Self-management capacity; Healthcare use; Wheather data; Air quality; Pollen; Medication delivery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov